Stockscreener 앱 받기
37.89
6.55%
2.33
시장 영업 전:
39.41
1.52
+4.01%
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Viking Therapeutics Inc. Builds Base for Possible ReboundCommunity Entry Consensus Trade Ideas Shared - beatles.ru
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts - AOL.com
Viking Therapeutics Surges 6.55% on High-Volume Momentum Ranking 373rd as Liquidity-Driven Strategy Yields 166.71% Return - AInvest
Viking Therapeutics Stock Climbs on Promising Drug Results - TipRanks
Viking Therapeutics' VK2735 maintains competitive edge despite disappointing Eli Lilly data. - AInvest
Viking Therapeutics' VK2735 Shows Promising Phase 1 Results, Justifying Buy Rating - AInvest
Viking Therapeutics Surges 11.54% to 408th in Volume Amid Eli Lilly's Setback - AInvest
Viking Therapeutics call volume above normal and directionally bullish - TipRanks
Why Viking Therapeutics Stock is Climbing - TipRanks
Promising Phase 1 Results for Viking Therapeutics’ VK2735 Justify Buy Rating - TipRanks
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors - Benzinga
Eli Lilly’s obesity drug data lifts Viking Therapeutics stock By Investing.com - Investing.com Canada
Three Stocks Showing Strong Buy Signals - AInvest
Is It Time to Buy Biotech Stocks? - The Motley Fool
Unlocking Viking Therapeutics' Potential with Upcoming Clinical Data - AInvest
Viking Therapeutics, Inc. (VKTX) Nears Obesity Drug Breakthrough with Phase 3 VK2735 Trial - MSN
Viking Therapeutics (VKTX) Is Considered a Good Investment by Brokers: Is That True? - MSN
This Biotech Stock Could Soar on Upcoming Clinical Data - AOL.com
Two Biotech Stocks with High Upside Potential: Viking Therapeutics and Recursion Pharmaceuticals - AInvest
What is the risk reward ratio of investing in Viking Therapeutics Inc. stockUnmatched market gains - Jammu Links News
VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales - The Globe and Mail
What institutional investors are buying Viking Therapeutics Inc. stockNavigate the market with precision tools - Jammu Links News
2 Beaten-Down Stocks With Incredible Upside Potential - Yahoo Finance
When is Viking Therapeutics Inc. stock expected to show significant growthIdentify safe investments with exceptional yields - Jammu Links News
What is the dividend policy of Viking Therapeutics Inc. stockExplosive earnings growth - Jammu Links News
What makes Viking Therapeutics Inc. stock price move sharplyGet professional advice for portfolio optimization - Jammu Links News
Is it the right time to buy Viking Therapeutics Inc. stockBuild a portfolio that stands the test of time - Jammu Links News
Is Viking Therapeutics Inc. stock overvalued or undervaluedFree Stock Selection - Jammu Links News
What are analysts’ price targets for Viking Therapeutics Inc. in the next 12 monthsMarket-beating returns - Jammu Links News
Is Viking Therapeutics the Next Big Biotech Bet? - AOL.com
Viking Therapeutics: A Promising Buy with Strategic Opportunities in Obesity Treatment and Direct-to-Consumer Market - TipRanks
Better Growth Buy: Eli Lilly vs. Viking Therapeutics - AOL.com
Viking Bets Big On Obesity And NASH With Dual-Agonist Pipeline - Finimize
Axsome Therapeutics and Viking Therapeutics: Biotech Stocks to WatchNews and Statistics - IndexBox
Wall Street Predicts Axsome Therapeutics and Viking Therapeutics Stocks to Soar 74% to 159% - AInvest
Why Viking Therapeutics Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - metal.it
Sentiment Turns Positive on Viking Therapeutics Inc. — Reversal AheadMarket Entry and Exit Point Tips From Traders - metal.it
How does Viking Therapeutics Inc. compare to its industry peersDynamic investment growth - Jammu Links News
Raymond James Financial Issues Pessimistic Forecast for Viking Therapeutics (NASDAQ:VKTX) Stock Price - MarketBeat
Why is Viking Therapeutics Inc. stock attracting strong analyst attentionTriple returns potential - Jammu Links News
What catalysts could drive Viking Therapeutics Inc. stock higher in 2025Rapid market gains - Jammu Links News
What are the technical indicators suggesting about Viking Therapeutics Inc.Unlock steady growth with low-risk stocks - jammulinksnews.com
Viking Therapeutics’ Earnings Call: Clinical Advances Amid Financial Challenges - TipRanks
0.24%
3.39%
자본화:
|
볼륨(24시간):